<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The gene IGF2, which encodes a fetal insulin-like growth factor, is imprinted, so only one of two parental copies of the gene is expressed </plain></SENT>
<SENT sid="1" pm="."><plain>The altered expression of IGF2 has been implicated in <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, a human fetal <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome, which is characterized by <z:hpo ids='HP_0001548'>overgrowth</z:hpo> of several organs and an increased risk of developing <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumours</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We have introduced Igf2 transgenes into the mouse genome by using embryonic stem cells, which leads to transactivation of the endogenous Igf2 gene </plain></SENT>
<SENT sid="3" pm="."><plain>The consequent overexpression of Igf2 results in most of the symptoms of <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, including prenatal <z:hpo ids='HP_0001548'>overgrowth</z:hpo>, <z:hpo ids='HP_0001561'>polyhydramnios</z:hpo>, fetal and <z:mp ids='MP_0002058'>neonatal lethality</z:mp>, disproportionate organ <z:hpo ids='HP_0001548'>overgrowth</z:hpo> including tongue enlargement, and <z:hpo ids='HP_0000924'>skeletal abnormalities</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>These phenotypes establish Igf2 overexpression as a key determinant of <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
</text></document>